Work

Targeted immunoediting of critical pathways responsible for breast cancer development: Treatment of early breast cancer using HER-2/neu pulsed dendritic cells.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Cancer Epidemiology and Prevention Biomarkers

Authors: Brian J. Czerniecki, Ursula Koldovsky, Shuwen Xu, Rosemarie Mick, Min Xu, Gilson Son, Harvey Nisenbaum, Paul J. Zhang, Gary K. Koski

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588910518

FWCI:

Cites:

Cited by:

Related to: 10